1,204 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Mining For ASCO 2018's Gold, Part 1: Early Breast Cancer Has Some Sheen https://seekingalpha.com/article/4176681-mining-asco-2018s-gold-part-1-early-breast-cancer-sheen?source=feed_sector_healthcare May 23, 2018 - Read up on upcoming potentially actionable events for the mid- to long-term coming out of 2018's biggest cancer meeting.Puma's drug seems to work a lot better if you can handle it for a long stretch.T
Celgene Wins One Bull, Loses Another On Revlimid Potential http://feeds.benzinga.com/~r/benzinga/~3/sjrX2CCUtIs/celgene-wins-one-bull-loses-another-on-revlimid-potenti May 23, 2018 -

Celgene Corporation (NASDAQ: CELG) is down about 35 percent year-over-year, and as management resists challenges to critical Revlimid patents, analysts are at odds about where the stock could head from here.

Is Celgene's Stock A Buy The Dip Opportunity? https://seekingalpha.com/article/4176396-celgenes-stock-buy-dip-opportunity?source=feed_sector_healthcare May 23, 2018 - Celgene's stock is in a downtrend but selling volume picked up on May 21 for no apparent reason.Investor confidence in management is lacking.Valuation multiples imply a deep discount.
Top 10 Market Movers With Insider Buying As Of May 17, 2018 https://seekingalpha.com/article/4176306-top-10-market-movers-insider-buying-may-17-2018?source=feed_all_articles May 22, 2018 - A list of the top 10 stocks in terms of total volume traded that also had insider buying. We provide in-depth analysis and ratings of each transaction. Only insider transactions that were executed on
Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas https://seekingalpha.com/article/4176184-core-biotech-buys-16-taking-advantage-weakness-add-conviction-ideas?source=feed_all_articles May 22, 2018 - Recent weakness in the biotech sector is an opportunity to add to conviction holdings.My ¨Week in Review¨ blog post appears to have the makings of a permanent feature due to positive feedback received
Celgene Forges Oncology Partnership With Germany's Evotec http://feeds.benzinga.com/~r/benzinga/~3/WL1nDk0JemE/celgene-forges-oncology-partnership-with-germanys-evotec May 22, 2018 -

Celgene Corporation (NASDAQ: CELG) — which is recently very much in the news, although for dubious reasons — has struck a read more

Celgene business development chief out last month https://seekingalpha.com/news/3358318-celgene-business-development-chief-last-month?source=feed_news_all May 21, 2018 - John Carroll reports that Celgene's (CELG -4.3%) business development head George Golumbeski quietly ended his nine-year stint at the biotech last month. His departure, mutually amicable according to
Main Small-Cap Index Russell 2000 Rallies to Record http://www.gurufocus.com/news/685152/main-smallcap-index-russell-2000-rallies-to-record May 21, 2018 - Main Small-Cap Index Russell 2000 Rallies to Record, Stocks: CELG,SYMC,MAT,NUE.HAS,MNRO,MU,BA,INTC,FL,CAT, release date:May 21, 2018
Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest https://seekingalpha.com/article/4175876-fda-shaming-drug-companies-financial-advisors-daily-digest?source=feed_tag_editors_picks May 21, 2018 - The FDA calls out Celgene, Actelion, Novartis, Gilead and other branded drug makers for anti-competitive behavior.Jeff Miller’s “Weighing the Week Ahead” takes on the fear that rising interest rates s
A Quantitative System To Invest In Quality Stocks https://seekingalpha.com/article/4175869-quantitative-system-invest-quality-stocks?source=feed_all_articles May 21, 2018 - Investing in quality stocks can be remarkably profitable in the long term.Quality can be hard to define, but some quantitative indicators are clear signs of underlying fundamental quality.Introducing

Pages: 123456...121

Page 1>
DeepLinks for Celgene
CELG - Google Finance https://www.google.com/finance?q=CELG Industry related info and international coverage Summary News
CELG - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=CELG Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options